| EPIC |
SCLP |
| Sector |
Pharma and Biotech |
| ISIN |
GB00B63D3314 |
| Market Sector |
AIM |
| Market Segment |
ASQ1 |
| Main Indices |
FTSE AIM All-Share, FTSE AIM 100 |
| Country of register |
Great Britain |
| Currency |
British Pound |
| Market Cap |
£116.98m |
| NMS |
20,000 |
| Shares in issue |
1,212.23m |
| Date Listed |
30-Jul-2010 |
| 11:03 |
250,000 @ 9.58p |
| 11:04 |
103,712 @ 9.64p |
| 11:04 |
25,000 @ 9.65p |
| 11:03 |
25,920 @ 9.65p |
| 11:00 |
500 @ 9.70p |
| CFO |
Sath Nirmalananthan |
| CEO |
Phil L'Huillier |
Top of Page
You are here:
research